Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>News>This Article

SmartKem Further Expands Team in Europe with Addition of Three New Recruits

Published: Monday, February 11, 2013
Last Updated: Monday, February 11, 2013
Bookmark and Share
COO and two scientists to join the Manchester team to support SmartKem’s growth plans.

SmartKem Limited has announced the appointment of three new team members in Europe. Dr. Hugh Williamson will be welcomed as Chief Operating Officer, whilst Dr. Muhammad Raza and Dr. Keith Lumbard will join as scientists at SmartKem’s dedicated chemistry synthesis labs in Manchester.

The last 12 months has seen SmartKem appoint staff in strategic locations across Asia and Europe to further strengthen its technical and commercial activities.

As SmartKem’s third senior appointment in the past six months, following the appointment of Bill Freer as Chairman in March and Gary Tam as Business Development Director in June, Dr. Williamson possesses over 30 years’ experience in the chemicals industry which will be shared in his position as Chief Operating Officer.

Previous roles have seen Dr. Williamson excel in the delivery and introduction of new chemical products at international level.

Having spent a number of years as a senior scientist at Kodak, Dr. Williamson’s global experience and proven ability to lead R&D and operations teams will be essential in supporting SmartKem’s commercialization strategy and the development of future technology.

Possessing over 40 years’ combined experience as synthetic chemists, Dr. Lumbard and Dr. Raza will be responsible for the development of next generation organic semiconductor molecules with enhanced performance to complement SmartKem’s already market-leading materials.

“Our latest recruits are another step forward in our vision to become the leading provider of high-mobility organic semiconductor materials and solutions for flexible display backplanes and organic circuits,’’ comments Steve Kelly, CEO at SmartKem.

Kelly continued, “Hugh was a natural appointment for us as Chief Operating Officer with his strong record of scaling novel organic synthesis methods into commercial processes. This further supports our strategy to maintain strong vertical integration in organic electronics - from molecule design to market application. The appointments of Keith and Muhammad as additional synthetic chemists demonstrate our commitment to develop ultra-high mobility organic semiconductors to meet future-market needs and to extend our leadership in the field. We are delighted to welcome them to the team.”

These new appointments promise to add strength, experience and expertise to the company in order to further develop its presence in the rapidly growing flexible electronics industry.

Together, the new members of the team will further support SmartKem’s mission of becoming the leading provider of, ‘p’ type organic semiconductor materials and solutions for ultra-thin and flexible electronics.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
New Hope for Personalized Treatment of Eczema
Pharmaceutical researchers at Oregon State University have developed a new approach to treat eczema and other inflammatory skin disorders that would use individual tests and advanced science to create personalized treatments based on each person's lipid deficiencies.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.
Researchers Disguise Drugs As Platelets to Target Cancer
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient’s own platelets.
HIV Patients Should Be Included in Early Clinical Trials of Anti-TB Drugs
Tuberculosis is the number one cause of death in HIV-infected patients in Africa and a leading cause of death in this population worldwide.
Combination Drug Therapy Shrinks Pancreatic Tumors In Mice
Two drugs that affect the structure and function of DNA have been found to block the growth of pancreatic tumor cells in mice, researchers hope the drugs can soon be tested in humans with the disease.
Seeking A Better Way To Design Drugs
NIH funds research at Worcester Polytechnic Institute to advance a new chemical process for more effective drug development and manufacturing.
Old Drug Performs New Tricks
Cambridge-led research reveals the powers of a "wonder drug" that has lain under the noses of doctors for 50 years.
Diabetes Drugs May Actually Release Sugar Into the Blood
A family of drugs used to treat Type 2 diabetes could promote the release of sugars into the blood - something the drugs are supposed to prevent, Cambridge scientists have claimed.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos